Page last updated: 2024-08-21

alpha-aminopyridine and Dementia, Vascular

alpha-aminopyridine has been researched along with Dementia, Vascular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chen, Z; Gao, Y; Guo, L; He, X; Huang, L; Huang, YY; Li, Z; Liang, J; Liang, SH; Luo, HB; Wu, D; Wu, R; Yu, S; Zhou, Q1
Dabertrand, F; Fontaine, JT; Joutel, A; Rosehart, AC1

Other Studies

2 other study(ies) available for alpha-aminopyridine and Dementia, Vascular

ArticleYear
Discovery and Optimization of α-Mangostin Derivatives as Novel PDE4 Inhibitors for the Treatment of Vascular Dementia.
    Journal of medicinal chemistry, 2020, 03-26, Volume: 63, Issue:6

    Topics: Aminopyridines; Animals; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Dementia, Vascular; Dogs; Drug Design; Humans; Male; Mice, Inbred C57BL; Molecular Structure; Phosphodiesterase 4 Inhibitors; Protein Binding; Rolipram; Structure-Activity Relationship; Vomiting; Xanthones

2020
HB-EGF depolarizes hippocampal arterioles to restore myogenic tone in a genetic model of small vessel disease.
    Mechanisms of ageing and development, 2020, Volume: 192

    Topics: Aminopyridines; Animals; Arterioles; Cerebral Small Vessel Diseases; Dementia, Vascular; Heparin-binding EGF-like Growth Factor; Hippocampus; Membrane Potentials; Membrane Transport Modulators; Mice; Microcirculation; Models, Genetic; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Potassium Channels, Voltage-Gated; Vasoconstriction

2020